Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.7680
+0.0100 (1.32%)
At close: Jul 30, 2026, 4:00 PM EDT
0.8060
+0.0380 (4.95%)
After-hours: Jul 30, 2026, 5:02 PM EDT
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $71.45 million as of July 30, 2026. Its market cap has increased by 158.03% in one year.
Market Cap
71.45M
Enterprise Value
71.74M
1-Year Change
158.03%
Ranking
Category
Stock Price
$0.77
ChartMarket Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.87M to $71.45M, a decrease of -55.02%. That is a compound annual growth rate of -8.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 71.45M | 134.34% |
| Dec 31, 2025 | 30.49M | -38.81% |
| Dec 31, 2024 | 49.83M | 234.56% |
| Dec 29, 2023 | 14.89M | 38.39% |
| Dec 30, 2022 | 10.76M | -78.89% |
| Dec 31, 2021 | 50.98M | 20.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeurAxis | 74.80M |
| Alps Group | 73.22M |
| MAIA Biotechnology | 72.96M |
| Atara Biotherapeutics | 72.62M |
| Annovis Bio | 72.32M |
| Gain Therapeutics | 72.09M |
| Spero Therapeutics | 68.90M |
| XBiotech | 68.60M |